Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (341-350 of 597) with videos related to

Pageof 60
Sort By:
Leukemia|February 1, 2023
Risk prediction in MDS: independent validation of the IPSS-M-ready for routine?Constance Baer, Sandra Huber, Stephan Hutter, et al.
Leukemia|May 11, 2024
Context-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysisHussein Awada, Arda Durmaz, Tariq Kewan, et al.
Cell Reports|July 5, 2024
Interface-guided phenotyping of coding variants in the transcription factor RUNX1Kivilcim Ozturk, Rebecca Panwala, Jeanna Sheen, et al.
Oncogene|July 25, 2003
Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interactionJanki Rangatia, Rajani K Vangala, Sheo M Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1Alexander Kohlmann, Vera Grossmann, Hans-Ulrich Klein, et al.
British Journal of Haematology|December 31, 2013
Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impactUlrike Bacher, Torsten Haferlach, Susanne Schnittger, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
A Unifying Mechanism for Shared Splicing Aberrations in Splicing Factor Mutant CancersPrajwal C Boddu, Rahul Roy, Stephen Hutter, et al.
Plos Computational Biology|August 31, 2019
Dark-matter matters: Discriminating subtle blood cancers using the darkest DNALaxmi Parida, Claudia Haferlach, Kahn Rhrissorrakrai, et al.
Haematologica|May 7, 2026
Lessons of nature from trisomy-8 myeloid neoplasia: the riddle of oncogenic clonal drivesHussein Awada, Arda Durmaz, Luca Guarnera, et al.
Haematologica|March 28, 2008
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID miceBrunangelo Falini, Maria Paola Martelli, Cristina Mecucci, et al.
Pageof 60

Showing results (341-350 of 597) with videos related to

Sort By:
Pageof 60
Leukemia|February 1, 2023
Risk prediction in MDS: independent validation of the IPSS-M-ready for routine?Constance Baer, Sandra Huber, Stephan Hutter, et al.
Leukemia|May 11, 2024
Context-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysisHussein Awada, Arda Durmaz, Tariq Kewan, et al.
Cell Reports|July 5, 2024
Interface-guided phenotyping of coding variants in the transcription factor RUNX1Kivilcim Ozturk, Rebecca Panwala, Jeanna Sheen, et al.
Oncogene|July 25, 2003
Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interactionJanki Rangatia, Rajani K Vangala, Sheo M Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1Alexander Kohlmann, Vera Grossmann, Hans-Ulrich Klein, et al.
British Journal of Haematology|December 31, 2013
Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impactUlrike Bacher, Torsten Haferlach, Susanne Schnittger, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
A Unifying Mechanism for Shared Splicing Aberrations in Splicing Factor Mutant CancersPrajwal C Boddu, Rahul Roy, Stephen Hutter, et al.
Plos Computational Biology|August 31, 2019
Dark-matter matters: Discriminating subtle blood cancers using the darkest DNALaxmi Parida, Claudia Haferlach, Kahn Rhrissorrakrai, et al.
Haematologica|May 7, 2026
Lessons of nature from trisomy-8 myeloid neoplasia: the riddle of oncogenic clonal drivesHussein Awada, Arda Durmaz, Luca Guarnera, et al.
Haematologica|March 28, 2008
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID miceBrunangelo Falini, Maria Paola Martelli, Cristina Mecucci, et al.
Pageof 60